Bet on Earnings, No...
Health Care: Drugs
Shire PLC (SHPGY: NASDAQ)
$90.23 1.38 | 1.55%
07/19/12 - 04:00 PM ET
Portfolios with SHPGY
- Portfolio NameUser Type
- ContributorRocket Stocks for the Week ...
- Contributor10 Pharmaceutical Stocks Wi...
- Contributor10 Biotech Stocks Facing FD...
- UserPART 4 JPMorgan 28th Annual...
- UserDartrx Portfolio 1
- ContributorBarron's 2009 Roundtable Pi...
- UserPART 4 JPMorgan 27th Annual...
- UserBarron's Summary 6-14-2008
- UserBarron's Research Reports 5...
- UserWirth Risk
Latest SHPGY Headlines from TheStreet
- Shire PLC (SHPGY): Today's Featured Drugs Loser 07.03.12 | 05:07 pm
- Shire PLC (SHPGY): Today's Featured Health Care Winner 05.11.12 | 04:05 pm
- Shire's CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.26.12 | 07:04 pm
- Shire PLC (SHPGY): Today's Featured Health Care Winner 04.26.12 | 05:04 pm
- Shire Stock To Go Ex-dividend Tomorrow (SHPGY) 03.06.12 | 08:03 am
- Five Reasons Chelsea Therapeutics' Northera Will Get FDA Approval 02.27.12 | 07:02 am
- Shire Stock Hits New 52-Week High (SHPGY) 02.13.12 | 08:02 am
- SHPGY: Trading Along the Flatline 11.28.11 | 11:11 am
- Shire Plc's CEO Discusses Q3 2011 Results - Earnings Call Transcript 10.28.11 | 04:10 pm
- Shire Stock To Go Ex-dividend Tomorrow (SHPGY) 09.06.11 | 09:09 am
Press Releases for SHPGY
- Shire Changes Its NASDAQ Ticker Symbol To SHPG - PR Newswire 07.09.12 | 11:07 am
- Shire's VPRIV® (velaglucerase Alfa For Injection) Shows Significant Improvement In Gaucher-Related Bone Disease - PR Newswire 06.28.12 | 06:06 am
- Shire Announces That The US Food And Drug Administration Has Responded To Its Citizen Petition For Adderall XR And Has Approved One Abbreviated New Drug Application For Generic Adderall XR - PR Newswire 06.23.12 | 10:06 am
- Shire's Advanced BioHealing Commits To Developing Regenerative Medicine Campus In San Diego - PR Newswire 06.11.12 | 08:06 am
- Shire Facebook Page Increases Awareness Of Hereditary Angioedema (HAE) In Support Of First HAE Awareness Day May 16th - PR Newswire 05.14.12 | 01:05 pm
- Shire To Present Scientific Data Across Range Of Psychiatric Disorders At American Psychiatric Association Annual Meeting May 5-9 - PR Newswire 05.04.12 | 09:05 am
- Shire Plc: First Quarter 2012 Results Date Notification - April 26, 2012 - PR Newswire 04.12.12 | 11:04 am
- Shire Adds New Technology Platform And Phase 2 Product Candidate To Its Regenerative Medicine Business - PR Newswire 04.12.12 | 09:04 am
- Shire Announces Top-line Results Of The PREVENT2 Trial - PR Newswire 03.30.12 | 07:03 am
- Shire Reaffirms Support Of Patients Requiring Midodrine HCl; Advances FDA Agreed Upon Clinical Trials - PR Newswire 03.29.12 | 04:03 pm
Partner Headlines for SHPGY
- DJIA Week in Review: Boeing's New Plane Takes Off, GE Climbs 5.2% - Wall St. Cheat Sheet 07.01.12 | 09:07 am
- Verizon DOUBTS on Galaxy S III DELAY and 4 Dow Players Making Moves - Wall St. Cheat Sheet 06.28.12 | 02:06 am
- Benzinga's Upgrade Summary for June 26, 2012 - Benzinga 06.26.12 | 01:06 pm
- Teva Jumps, But Still Must Repair Its Chart Further - Investor's Business Daily 06.25.12 | 05:06 pm
- Stocks Edge Off Session Lows; Teva, Anheuser Busch Climb - Investor's Business Daily 06.25.12 | 03:06 pm
- Stocks Near Lows In Afternoon; Drugmaker Shire Drops - Investor's Business Daily 06.25.12 | 01:06 pm
- Zillow Shares Will CONTINUE Climb and 4 More Fresh Stock Insights - Wall St. Cheat Sheet 06.25.12 | 12:06 pm
- Merck's Osteoporosis Drug Receives INCREASED Attention and 4 More HOT Stock Insights - Wall St. Cheat Sheet 06.25.12 | 12:06 pm
- Generic Adderall XR APPROVAL Means PRESSURE for Shire and 4 More Stock Insights - Wall St. Cheat Sheet 06.25.12 | 12:06 pm
- Augme Technologies Patent Portfolio GROWS and 4 More Fresh Equity Insights - Wall St. Cheat Sheet 06.25.12 | 11:06 am
